跳至主要内容
临床试验/JPRN-UMIN000044213
JPRN-UMIN000044213招募中未知

A prospective observational study to investigate the safety of SARS-Cov-2 vaccine for patients with advanced lung cancer who are treated with immune checkpoint inhibitor. - Association between immune related adverse events and novel coronavirus vaccine for advanced lung cancer patients

Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital0 个研究点目标入组 100 人开始时间: 2021年5月14日最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients that doctor in charge consider them inappropriate as a subject Patients who had already infected with COVID-19

研究者

相似试验

A prospective observational study to investigate the... | 临床试验